Details for Patent: 7,964,202
✉ Email this page to a colleague
Which drugs does patent 7,964,202 protect, and when does it expire?
Patent 7,964,202 protects EPIDUO and is included in one NDA.
This patent has thirty-three patent family members in twenty-two countries.
Summary for Patent: 7,964,202
| Title: | Method for treatment of common acne |
| Abstract: | Dermatological/cosmetic compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise, in a physiologically acceptable medium, (i) at least one dispersed retinoid, (ii) dispersed benzoyl peroxide, in free or encapsulated form, and (iii) at least one pH-independent gelling agent, said dermatological/cosmetic composition having physical stability without loss of viscosity over time at a temperature ranging from 4.degree. C. to 40.degree. C., said dermatological/cosmetic composition having a stable flow threshold over time as measured by viscosity measurements for rheograms which measure a shear stress .tau. for a given rate gradient .gamma. and which measure a rate gradient .gamma. for a given shear stress .tau., the yield value (.tau.0) being extrapolated visually or by calculation. |
| Inventor(s): | Orsoni; Sandrine (Mandelieu, FR), Willcox; Nathalie (Le Rouret, FR) |
| Assignee: | Galderma Research & Development, S.N.C. (FR) |
| Application Number: | 12/076,859 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,964,202
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | EPIDUO | adapalene; benzoyl peroxide | GEL;TOPICAL | 022320-001 | Dec 8, 2008 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF ACNE | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,964,202
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| France | 01 16747 | Dec 21, 2001 |
International Family Members for US Patent 7,964,202
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1458369 | ⤷ Sign Up | CA 2008 00029 | Denmark | ⤷ Sign Up |
| European Patent Office | 1458369 | ⤷ Sign Up | 08C0024 | France | ⤷ Sign Up |
| European Patent Office | 1458369 | ⤷ Sign Up | SPC/GB10/005 | United Kingdom | ⤷ Sign Up |
| European Patent Office | 1458369 | ⤷ Sign Up | C01458369/01 | Switzerland | ⤷ Sign Up |
| European Patent Office | 1458369 | ⤷ Sign Up | 380 | Finland | ⤷ Sign Up |
| European Patent Office | 1458369 | ⤷ Sign Up | SZ 31/2008 | Austria | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
